| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.9M | -5.0% | +8.6% |
| SG&A Expense | $1.8M | -31.2% | -19.3% |
| Operating Income | -$5.6M | +15.1% | +2.1% |
| Income Tax | $0 | — | — |
| Net Income | -$7.8M | -31.0% | -38.9% |
| EPS (Basic) | -$0.52 | -30.0% | -4.0% |
| EPS (Diluted) | -$0.52 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.5M | -7.6% | -40.2% |
| Short-term Investments | $8.6M | -28.4% | +58.0% |
| Current Assets | $14.9M | -21.7% | -5.3% |
| Total Assets | $14.9M | -21.8% | -8.0% |
| Current Liabilities | $3.7M | +5.9% | -2.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.3M | — | — |
| Capital Expenditures | $22K | — | — |
| Investing Cash Flow | $2.4M | — | — |
| Financing Cash Flow | $11.5M | — | — |
| Free Cash Flow | -$16.3M | — | — |
| -4.0% |
| $15.2M |
| +17.0% |
| +111.4% |
| Stockholders' Equity | -$268K | -104.4% | -103.0% |